A Colorful Cure: How Gene Therapy Is Treating Blue Cone Monochromacy
Blue cone monochromacy is a rare X-linked retina disorder. It causes a complete or near-complete loss of function in the L- and M-cones responsible for color vision.
Stay updated with breaking news from Blue Cone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Blue cone monochromacy is a rare X-linked retina disorder. It causes a complete or near-complete loss of function in the L- and M-cones responsible for color vision.
The ultimate Instagrammable hotel 😍 This hotel isn't cheap, but the experience is worth it!
The TreeHotel Biosphere is a floating hotel room that is covered in hundreds of birdhouses to preserve the local bird population.
Home / Top News / Adverum Biotechnologies Presents Long-term Data through March 10, 2021 from the OPTIC Trial of ADVM-022 Intravitreal Gene Therapy in Treatment-experienced Wet AMD Patients at ARVO 2021 Adverum Biotechnologies Presents Long-term Data through March 10, 2021 from the OPTIC Trial of ADVM-022 Intravitreal Gene Therapy in Treatment-experienced Wet AMD Patients at ARVO 2021 AC – Inflammation was Mild and Decreasing over Time in Cohort 3 AC – Inflammation was Mild and Decreasing over Time in Cohort 3 VC – Inflammation was Mild and Decreasing over Time in Cohort 3 VC – Inflam...